You are here
This report was prepared in accordance with the requirements of the National Health Reform Act 2011 and section 46 of the Public Governance, Performance and Accountability Act 2013. The report is a formal accountability document that details the activities of the Independent Hospital Pricing Authority (IHPA) from 1 July 2017 – 30 June 2018.
This document provides background to the development of the new classification, explains the data elements and collection protocols, reporting requirements, and how the data is grouped.
This document provides an overview of the content of the ATTC Version 1.0 including the scope, structure and relevant activities.
Hospital Teaching, Training and Research Activities National Best Endeavours Data Set 2018-19 Technical Specifications for reporting5 July 2018
This document outlines the reporting requirements for the provision of data against the HTTRA NBEDS 2018-19 by state and territory health departments, including:
The Australian Hospital Patient Costing Standards (AHPCS) provide direction for hospital patient costing through the development of standards for specific elements of the costing process and reporting requirements.
The AHPCS Version 4.0 was developed through extensive consultation with jurisdictions and stakeholders. The AHPCS Version 4.0 comprises:
This guide is intended to provide assistance when assigning care types, especially for those patients that may potentially have care that applies to more than one care type.
This report is prepared in accordance with the Requirements for Annual Reports, as issued by the Department of the Prime Minister and Cabinet and approved by the Joint Committee of Public Accountants Audit under sub sections 63(2) and 70(2) of the Public Service Act 1999. The report is a formal accountability document that details the activities of the Independent Hospital Pricing Authority (IHPA) from 1 July 2014 – 30 June 2015.
IHPA has developed a robust set of standard costs for the revised List of standard items associated with conducting clinical trials in Australia.